<DOC>
	<DOCNO>NCT00129246</DOCNO>
	<brief_summary>This study test combination drug naltrexone bupropion weight-concerned smoker investigate whether combination drug improve smoke cessation quit rate minimize post quit weight gain .</brief_summary>
	<brief_title>Low-Dose Naltrexone Combined With Bupropion Stop Smoking With Less Weight Gain</brief_title>
	<detailed_description>This open label smoke cessation clinical trial 25 mg naltrexone 300 mg bupropion sustained-release ( SR ) six male fourteen female participant . This pilot study conduct determine : - effect size estimate smoke cessation post-cessation weight gain , use compute sample size need large-scale clinical trial ; - compliance combination 25 mg naltrexone 300 mg bupropion SR . In addition examine sample study , investigator plan compare sample sample match control .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Weight Gain</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Ages 18 old Willingness ability give write consent Smoking least 10 cigarette per day least 1 year Baseline expire carbonmonoxide level least 10 ppm Weigh least 100 lb . Englishspeaking One person per household At least 1 prior quit attempt Concern gain weight . This assess use questionnaire provide rating system determine qualified participant . Pregnant nursing woman woman attempt conceive Serious current neurologic , psychiatric medical illness , include unstable cardiac , hepatic , renal disease diabetes hypertension Current alcohol dependence Current use opiate , and/or urine toxicology screen positive opiates Chronic pain condition necessitate opioid treatment ( naltrexone , opioid antagonist make medication ineffective ) Evidence significant hepatocellular injury evidence AST ALT &gt; 3 x normal elevate bilirubin History cirrhosis Body mass index ( BMI ) great 35 History anorexia nervosa bulimia Current major depression Currently take ToprolXL ( metoprolol succinate ) History seizure disorder serious brain injury Current use smokeless tobacco , pipe , cigar , nicotine gum , nicotine patch , nicotine inhaler , nicotine lozenge , nicotine nasal spray , bupropion Previous hypersensitivity bupropion Patients require concomitant therapy psychotropic drug Participation Framing Messages Smoking Cessation With Bupropion study ( HIC # : 10880 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Tobacco</keyword>
	<keyword>Smoking</keyword>
	<keyword>Weight</keyword>
	<keyword>Weight perception</keyword>
	<keyword>Naltrexone</keyword>
	<keyword>Bupropion</keyword>
</DOC>